Related Experiment Videos
Nitric oxide modulates synaptic glutamate release during anoxia
1Department of Neurology, Georgetown University Medical Center, Washington, DC 20007, USA.
Neuroscience Letters
|May 30, 1997
Summary
Nitric oxide (NO) enhances glutamate release from vesicles during oxygen deprivation (anoxia). This NO-mediated enhancement of synaptic glutamate release may contribute to excitotoxicity in hypometabolic states.
Area of Science:
- Neuroscience
- Neurophysiology
- Molecular Biology
Background:
- Nitric oxide (NO) is a signaling molecule implicated in various physiological processes.
- Glutamatergic neurotransmission is crucial for synaptic plasticity and function in the central nervous system.
- Anoxia, or oxygen deprivation, can lead to altered neuronal activity and excitotoxicity.
Purpose of the Study:
- To investigate the role of nitric oxide (NO) in modulating vesicular glutamate release during anoxia.
- To determine the involvement of N-methyl-D-aspartate (NMDA) receptors in NO-mediated effects on synaptic transmission under anoxic conditions.
Main Methods:
- Whole-cell patch clamp recordings were performed on CA1 pyramidal neurons in rat hippocampal slices.
- Tetrodotoxin was used to isolate spontaneous glutamatergic miniature excitatory postsynaptic currents (mEPSCs).
- The effects of NO-synthase inhibitors, reduced hemoglobin, NMDA receptor antagonists, and arginine were assessed during anoxia.
Main Results:
- Anoxia exposure increased the frequency of mEPSCs in CA1 pyramidal neurons.
- Inhibition of NO production (using NO-synthase inhibitors or reduced hemoglobin) attenuated the anoxia-induced increase in mEPSC frequency.
- NMDA receptor antagonists also suppressed the anoxia-induced increase in mEPSC frequency.
- Supplementation with arginine reversed the inhibitory effects of NO-synthase inhibitors.
Conclusions:
- NMDA receptor activation leads to NO production, which enhances vesicular synaptic glutamate release during anoxia.
- This NO-mediated enhancement of glutamate release may contribute to excitotoxicity during hypometabolic states such as stroke or cardiac arrest.